ARCHIVES

Investigators Testing Ways To Overcome Gleevec Resistance: High Dose, New Drugs

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 16, 1998

ASCO proposes compromise to limit payment cuts proposed by Congress, CMS.

September 12, 2003

First Lady Helps Dedicate New MDA Facilities

October 15, 1976

Five-Fold Increase in Chordoma Risk Linked to Common Gene Variant

October 26, 2012

NCI Staff Working Group Leans Toward Starting COP With Community Hospitals As Lead Funding Agencies

January 1, 1982

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978